- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03987321
Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter
June 13, 2019 updated by: Yonsei University
Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter: A Prospective, Randomized, Comparative Study
The primary purpose of this study is to compare the Celect and Denali filters in terms of complicated filter retrieval and indwelling complications after a 2-month indwelling time.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
With anticoagulation being the standard treatment for deep venous thrombosis and pulmonary embolism, inferior vena cava filter placement plays an important role in patients who are amenable to anticoagulant therapy.
Currently, many different types of retrievable filters are being used in clinical practice and the choice of the filters depends on operators' preference and institutional availability.
Each filter has different designs to maximize retrievability and minimize indwelling complications.
Up until now, the prior studies on the filter retrievability and indwelling complications have been retrospective in nature and had relatively long dwell times.
Comparative data regarding the retrievability of the inferior vena cava filters may help to choose filter selection.
Therefore, the aim of this trial is to compare two commonly used inferior vena cava filters (Denali and Celet filters)
Study Type
Interventional
Enrollment (Anticipated)
174
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Department of Radiology, Severance hospital, Yonsei College of Medicine
-
Contact:
- Man Deuk Kim, MD, Ph.D
- Phone Number: 82-2-2228-7400
- Email: mdkim@yuhs.ac
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 1. Patients who develop deep venous thrombosis and/or pulmonary embolism but are good candidates for anticoagulant therapy
- 2. Inferior vena cava filtration before mechanical thrombectomy for deep venous thrombosis
- 3. Prophylactic filter placement because of trauma or major surgery
Exclusion Criteria:
- 1. Sepsis
- 2. Those who need permanent filter placement
- 3. Congenital anatomical anomaly (IVC duplication, interrupted IVC)
- 4. patients who need filter placement in the suprarenal inferior vena cava
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Denali Group
Those who received Denali filter placement
|
Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava.
All other procedures are the same in both groups
|
|
EXPERIMENTAL: Celect Group
Those who received Celect filter placement
|
Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava.
All other procedures are the same in both groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of complicated filter retrieval
Time Frame: 2 months after filter placement
|
Incidence of retrieval cases that require the use of standard retrieval kit (sheath and snare)
|
2 months after filter placement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of penetration
Time Frame: 2 months after filter placement
|
2 months after filter placement
|
|
|
tilt angle
Time Frame: 2 months after filter placement
|
2 months after filter placement
|
|
|
Filter migration
Time Frame: 2 months after filter placement
|
Filter migration is a change in filter position com-pared with its deployed position (cranial or caudal) of more than 2 cm as documented by diagnostic imaging.
|
2 months after filter placement
|
|
fracture
Time Frame: 2 months after filter placement
|
Filter fracture is any loss of a filter's structural integrity(ie, breakage or separation) documented by imaging.
|
2 months after filter placement
|
|
signs of inferior vena cava occlusion/stenosis
Time Frame: 2 months after filter placement
|
Any signs of narrowing or obstruction of the IVC where the IVC filter was inserted as documented by CT.
|
2 months after filter placement
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
July 1, 2019
Primary Completion (ANTICIPATED)
May 1, 2020
Study Completion (ANTICIPATED)
June 1, 2020
Study Registration Dates
First Submitted
May 26, 2019
First Submitted That Met QC Criteria
June 13, 2019
First Posted (ACTUAL)
June 17, 2019
Study Record Updates
Last Update Posted (ACTUAL)
June 17, 2019
Last Update Submitted That Met QC Criteria
June 13, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-2019-0020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.